Biblio print

Tree Display

AceDB Schema

XML Display


Author Report for: Johnson E

Contact information:

Johnson Edwin
Neuroscience Department, AstraZeneca Pharmaceuticals LP, 1800 Concord Pike, FRC B1129B, Wilmington, DE 19850
Phone :
Fax :

    Title: Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation
    Chen LS, Baker TB, Jorenby D, Piper M, Saccone N, Johnson E, Breslau N, Hatsukami D, Carney RM, Bierut LJ
    Ref: Drug Alcohol Depend, 154:278, 2015 : PubMed


    Title: Comparative proteomic profiling of dystroglycan-associated proteins in wild type, mdx, and Galgt2 transgenic mouse skeletal muscle
    Yoon JH, Johnson E, Xu R, Martin LT, Martin PT, Montanaro F
    Ref: J Proteome Res, 11:4413, 2012 : PubMed


    Title: Poster: Attentional improvement in rats with the nicotinic agonist AZ12564698 (AZD3480)
    Rezvani AH, Cauley M, Johnson E, Levin ED
    Ref: Biochemical Pharmacology, 82:1040, 2011 : PubMed


    Title: Selective alpha7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes
    Sydserff S, Sutton EJ, Song D, Quirk MC, Maciag C, Li C, Jonak G, Gurley D, Gordon JC and Smith JS <9 more author(s)>
    Ref: Biochemical Pharmacology, 78:880, 2009 : PubMed


    Title: Analysis of the DNA sequence and duplication history of human chromosome 15
    Zody MC, Garber M, Sharpe T, Young SK, Rowen L, O'Neill K, Whittaker CA, Kamal M, Chang JL and Nusbaum C <58 more author(s)>
    Ref: Nature, 440:671, 2006 : PubMed


Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page

Acknowledgements and disclaimer